The UK’s pharma industry has welcomed Theresa May's hard won agreement with EU leaders on Brexit, which is already threatened by intense political infighting.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.